Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Periodicals
Tesla, U.K. government rumored to be working on factory, Electrek says » 11:32
06/03/20
06/03
11:32
06/03/20
11:32
TSLA

Tesla

$892.25 /

+10.75 (+1.22%)

A rumor is circulating…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$892.25 /

+10.75 (+1.22%)

TSLA Tesla
$892.25 /

+10.75 (+1.22%)

06/01/20 Morgan Stanley
SpaceX success has bearing on market's perception of Tesla, says Morgan Stanley
05/29/20
Fly Intel: Top five analyst initiations
05/29/20 Daiwa
Tesla initiated with an Outperform at Daiwa
05/28/20 Morgan Stanley
Tesla shift to software revenue key to unlocking bull case, says Morgan Stanley
TSLA Tesla
$892.25 /

+10.75 (+1.22%)

TSLA Tesla
$892.25 /

+10.75 (+1.22%)

TSLA Tesla
$892.25 /

+10.75 (+1.22%)

TSLA Tesla
$892.25 /

+10.75 (+1.22%)

TSLA Tesla
$892.25 /

+10.75 (+1.22%)

Periodicals
Administration to ban Chinese passenger carriers from U.S. flights, Reuters says » 09:51
06/03/20
06/03
09:51
06/03/20
09:51
SPY

SPDR S&P 500 ETF Trust

$310.37 /

+2.24 (+0.73%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

, ALK

Alaska Air

$37.75 /

+1.56 (+4.31%)

, LUV

Southwest

$35.25 /

+0.76 (+2.20%)

, DAL

Delta Air Lines

$26.93 /

+0.51 (+1.93%)

, JBLU

JetBlue

$10.62 /

+0.31 (+3.01%)

, UAL

United Airlines

$30.70 /

+0.79 (+2.64%)

, SAVE

Spirit Airlines

$15.00 /

+0.51 (+3.52%)

, AAL

American Airlines

$11.53 /

+0.325 (+2.90%)

The Trump administration…

The Trump administration plans to announce plans Wednesday to ban Chinese passenger carriers from flying to the United States starting in mid-June, according to Reuters, citing officials briefed on the matter. The White House and Department of Transportation denied comment to Reuters on the matter. Restrictions are expected to take effect June 16, but could be moved up, the people briefed on the matter told Reuters. The report notes that Delta (DAL) and United (UAL) have asked to resume flights to China this month and that Chinese carriers have continued U.S. flights during the pandemic. Other publicly traded U.S. air carriers include Alaska Air (ALK), American Airlines (AAL), JetBlue (JBLU), Southwest (LUV) and Spirit Airlines (SAVE). Reference Link

ShowHide Related Items >><<
UAL United Airlines
$30.70 /

+0.79 (+2.64%)

SPY SPDR S&P 500 ETF Trust
$310.37 /

+2.24 (+0.73%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SAVE Spirit Airlines
$15.00 /

+0.51 (+3.52%)

LUV Southwest
$35.25 /

+0.76 (+2.20%)

JBLU JetBlue
$10.62 /

+0.31 (+3.01%)

DAL Delta Air Lines
$26.93 /

+0.51 (+1.93%)

ALK Alaska Air
$37.75 /

+1.56 (+4.31%)

AAL American Airlines
$11.53 /

+0.325 (+2.90%)

SPY SPDR S&P 500 ETF Trust
$310.37 /

+2.24 (+0.73%)

03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
12/16/19 Piper Sandler
Piper establishes 2020 S&P 500 price objective of 3,600
SPX S&P 500
$0.00 /

+ (+0.00%)

ALK Alaska Air
$37.75 /

+1.56 (+4.31%)

05/29/20 Wolfe Research
Alaska Air upgraded to Outperform from Peer Perform at Wolfe Research
05/04/20 Barclays
Barclays downgrades U.S. Airlines sector along with American and Delta
05/04/20 Barclays
Alaska Air price target lowered to $35 from $44 at Barclays
04/21/20 Deutsche Bank
Alaska Air price target lowered to $45 from $52 at Deutsche Bank
LUV Southwest
$35.25 /

+0.76 (+2.20%)

05/26/20
Fly Intel: Top five analyst upgrades
05/26/20 UBS
Southwest upgraded to Buy from Neutral at UBS
05/19/20 Goldman Sachs
Southwest, United seeing modest improvements in demand, says Goldman Sachs
DAL Delta Air Lines
$26.93 /

+0.51 (+1.93%)

05/04/20 Barclays
Delta Air Lines downgraded to Equal Weight from Overweight at Barclays
04/23/20 Raymond James
Delta Air Lines price target lowered to $36 from $40 at Raymond James
04/21/20 Deutsche Bank
Delta Air Lines price target lowered to $47 from $51 at Deutsche Bank
JBLU JetBlue
$10.62 /

+0.31 (+3.01%)

05/04/20 Barclays
JetBlue price target lowered to $11 from $16 at Barclays
04/21/20
Fly Intel: Top five analyst downgrades
04/21/20 Susquehanna
JetBlue downgraded to Neutral at Susquehanna
UAL United Airlines
$30.70 /

+0.79 (+2.64%)

05/26/20 Citi
Lufthansa bailout 'marginally positive' for United Airlines,says Citi
05/04/20 Barclays
United Airlines price target lowered to $40 from $60 at Barclays
SAVE Spirit Airlines
$15.00 /

+0.51 (+3.52%)

05/29/20 Wolfe Research
Spirit Airlines downgraded to Underperform from Peer Perform at Wolfe Research
05/18/20 Evercore ISI
Spirit Airlines upgraded to Outperform from In Line at Evercore ISI
05/13/20
Fly Intel: Top five analyst downgrades
05/13/20 Raymond James
Spirit Airlines downgraded to Market Perform from Outperform at Raymond James
AAL American Airlines
$11.53 /

+0.325 (+2.90%)

05/04/20 Barclays
American Airlines downgraded to Underweight from Equal Weight at Barclays
05/01/20 Evercore ISI
American Airlines price target lowered to $1 from $10 at Evercore ISI
04/27/20 Citi
American Airlines price target lowered to $10 from $13 at Citi
UAL United Airlines
$30.70 /

+0.79 (+2.64%)

SPY SPDR S&P 500 ETF Trust
$310.37 /

+2.24 (+0.73%)

SAVE Spirit Airlines
$15.00 /

+0.51 (+3.52%)

LUV Southwest
$35.25 /

+0.76 (+2.20%)

JBLU JetBlue
$10.62 /

+0.31 (+3.01%)

DAL Delta Air Lines
$26.93 /

+0.51 (+1.93%)

ALK Alaska Air
$37.75 /

+1.56 (+4.31%)

AAL American Airlines
$11.53 /

+0.325 (+2.90%)

UAL United Airlines
$30.70 /

+0.79 (+2.64%)

SPY SPDR S&P 500 ETF Trust
$310.37 /

+2.24 (+0.73%)

LUV Southwest
$35.25 /

+0.76 (+2.20%)

JBLU JetBlue
$10.62 /

+0.31 (+3.01%)

DAL Delta Air Lines
$26.93 /

+0.51 (+1.93%)

ALK Alaska Air
$37.75 /

+1.56 (+4.31%)

AAL American Airlines
$11.53 /

+0.325 (+2.90%)

UAL United Airlines
$30.70 /

+0.79 (+2.64%)

SPY SPDR S&P 500 ETF Trust
$310.37 /

+2.24 (+0.73%)

SAVE Spirit Airlines
$15.00 /

+0.51 (+3.52%)

LUV Southwest
$35.25 /

+0.76 (+2.20%)

JBLU JetBlue
$10.62 /

+0.31 (+3.01%)

DAL Delta Air Lines
$26.93 /

+0.51 (+1.93%)

ALK Alaska Air
$37.75 /

+1.56 (+4.31%)

AAL American Airlines
$11.53 /

+0.325 (+2.90%)

UAL United Airlines
$30.70 /

+0.79 (+2.64%)

SPY SPDR S&P 500 ETF Trust
$310.37 /

+2.24 (+0.73%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SAVE Spirit Airlines
$15.00 /

+0.51 (+3.52%)

LUV Southwest
$35.25 /

+0.76 (+2.20%)

JBLU JetBlue
$10.62 /

+0.31 (+3.01%)

DAL Delta Air Lines
$26.93 /

+0.51 (+1.93%)

ALK Alaska Air
$37.75 /

+1.56 (+4.31%)

AAL American Airlines
$11.53 /

+0.325 (+2.90%)

SPY SPDR S&P 500 ETF Trust
$310.37 /

+2.24 (+0.73%)

SPX S&P 500
$0.00 /

+ (+0.00%)

Periodicals
Tesla employee tests positive for COVID-19 at Buffalo factory, The Verge says » 09:41
06/03/20
06/03
09:41
06/03/20
09:41
TSLA

Tesla

$881.50 /

+ (+0.00%)

, PCRFY

Panasonic

$0.00 /

+ (+0.00%)

A Tesla (TSLA) employee…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$881.50 /

+ (+0.00%)

PCRFY Panasonic
$0.00 /

+ (+0.00%)

TSLA Tesla
$881.50 /

+ (+0.00%)

06/01/20 Morgan Stanley
SpaceX success has bearing on market's perception of Tesla, says Morgan Stanley
05/29/20
Fly Intel: Top five analyst initiations
05/29/20 Daiwa
Tesla initiated with an Outperform at Daiwa
05/28/20 Morgan Stanley
Tesla shift to software revenue key to unlocking bull case, says Morgan Stanley
PCRFY Panasonic
$0.00 /

+ (+0.00%)

04/22/20 UBS
Panasonic downgraded to Sell from Neutral at UBS
03/16/20 Citi
Panasonic upgraded to Buy from Neutral at Citi
08/27/19 Citi
Panasonic downgraded to Neutral from Buy at Citi
08/01/19 Jefferies
Panasonic downgraded to Hold from Buy at Jefferies
TSLA Tesla
$881.50 /

+ (+0.00%)

TSLA Tesla
$881.50 /

+ (+0.00%)

PCRFY Panasonic
$0.00 /

+ (+0.00%)

TSLA Tesla
$881.50 /

+ (+0.00%)

PCRFY Panasonic
$0.00 /

+ (+0.00%)

TSLA Tesla
$881.50 /

+ (+0.00%)

TSLA Tesla
$881.50 /

+ (+0.00%)

Yesterday
Periodicals
Tesla worker tests positive for COVID-19 at NY facility, The Verge says » 17:36
06/02/20
06/02
17:36
06/02/20
17:36
TSLA

Tesla

$881.50 /

-16.54 (-1.84%)

According to internal…

According to internal Tesla emails obtained by The Verge, "a Panasonic employee at Tesla's solar panel factory in Buffalo, New York," tested positive in March for COVID-19, writes Sean O'Kane of The Verge. According to The Verge, it is the fourth known Tesla facility employee to test positive for the virus "following one at the Gigafactory in Nevada, and two office workers in California." "The infected employee was not in the office after March 17th, according to the emails, which a current employee provided to The Verge on the condition of anonymity," added The Verge. Reference Link

ShowHide Related Items >><<
TSLA Tesla
$881.50 /

-16.54 (-1.84%)

TSLA Tesla
$881.50 /

-16.54 (-1.84%)

06/01/20 Morgan Stanley
SpaceX success has bearing on market's perception of Tesla, says Morgan Stanley
05/29/20
Fly Intel: Top five analyst initiations
05/29/20 Daiwa
Tesla initiated with an Outperform at Daiwa
05/28/20 Morgan Stanley
Tesla shift to software revenue key to unlocking bull case, says Morgan Stanley
TSLA Tesla
$881.50 /

-16.54 (-1.84%)

TSLA Tesla
$881.50 /

-16.54 (-1.84%)

TSLA Tesla
$881.50 /

-16.54 (-1.84%)

TSLA Tesla
$881.50 /

-16.54 (-1.84%)

TSLA Tesla
$881.50 /

-16.54 (-1.84%)

Hot Stocks
Digital Ally launches non-contact thermometer, sanitizer in response to pandemic » 09:56
06/02/20
06/02
09:56
06/02/20
09:56
DGLY

Digital Ally

$1.66 /

-0.29 (-14.87%)

Digital Ally announced…

Digital Ally announced the launch of two product lines "in direct response to the increased safety precautions organizations and individuals are taking due to the Covid-19 pandemic." ThermoVu is a non-contact temperature-measuring instrument that measures temperature through the wrist and controls entry to facilities when temperature measurements exceed pre-determined parameters, Digital Ally said. The company is also launching its Shield disinfectant/sanitizer and several related products to "fulfill demand by current customers and others for a disinfectant and sanitizer that is less harsh than many of the traditional products now widely distributed," the company added.

ShowHide Related Items >><<
DGLY Digital Ally
$1.66 /

-0.29 (-14.87%)

DGLY Digital Ally
$1.66 /

-0.29 (-14.87%)

  • 02
    Jun
DGLY Digital Ally
$1.66 /

-0.29 (-14.87%)

DGLY Digital Ally
$1.66 /

-0.29 (-14.87%)

Syndicate
Digital Ally 3.1M share Secondary priced at $1.65 » 09:18
06/02/20
06/02
09:18
06/02/20
09:18
DGLY

Digital Ally

$1.95 /

+0.84 (+75.68%)

Aegis acted as sole book…

Aegis acted as sole book running manager for the offering.

ShowHide Related Items >><<
DGLY Digital Ally
$1.95 /

+0.84 (+75.68%)

DGLY Digital Ally
$1.95 /

+0.84 (+75.68%)

DGLY Digital Ally
$1.95 /

+0.84 (+75.68%)

DGLY Digital Ally
$1.95 /

+0.84 (+75.68%)

Options
Notable open interest changes for June 2nd » 08:55
06/02/20
06/02
08:55
06/02/20
08:55
ECL

Ecolab

$209.13 /

-3.72 (-1.75%)

, PFE

Pfizer

$35.47 /

-2.67 (-7.00%)

, TSLA

Tesla

$898.04 /

+63.87 (+7.66%)

, ZM

Zoom Video

$204.15 /

+24.52 (+13.65%)

Monday's total…

Monday's total option volume of 21.1 million contracts resulted in net open interest growth of 3.71 million calls and 2.85 million puts. Ecolab (ECL), Pfizer (PFE), Tesla (TSLA) and Zoom Video Communications (ZM) saw the greatest growth. Top five new positions opened include 86k Ecolab (ECL) 6/12 weekly 290 calls, 85k Ecolab (ECL) 6/12 weekly 290 puts, 47k Ecolab (ECL) 6/5 weekly 275 calls, 47k Ecolab (ECL) 6/5 weekly 275 puts and 26k Apergy (APY) Jun-20 15 puts.

ShowHide Related Items >><<
ZM Zoom Video
$204.15 /

+24.52 (+13.65%)

TSLA Tesla
$898.04 /

+63.87 (+7.66%)

PFE Pfizer
$35.47 /

-2.67 (-7.00%)

ECL Ecolab
$209.13 /

-3.72 (-1.75%)

ECL Ecolab
$209.13 /

-3.72 (-1.75%)

04/16/20 Spin-Off Research
Ecolab initiated with a Hold at Spin-Off Research
04/06/20 BMO Capital
Ecolab price target lowered to $171 from $216 at BMO Capital
03/20/20 Deutsche Bank
Ecolab price target lowered to $170 from $220 at Deutsche Bank
03/17/20 JPMorgan
JPMorgan downgrades Ecolab to Underweight, cuts target to $152
PFE Pfizer
$35.47 /

-2.67 (-7.00%)

06/01/20 Morgan Stanley
Lilly trial has higher risk and reward after Pfizer failure, says Morgan Stanley
06/01/20 Barclays
Pfizer price target lowered to $35 from $37 at Barclays
05/21/20 Piper Sandler
Gilead's filgotinib likely being underestimated by Street, says Piper Sandler
05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
TSLA Tesla
$898.04 /

+63.87 (+7.66%)

06/01/20 Morgan Stanley
SpaceX success has bearing on market's perception of Tesla, says Morgan Stanley
05/29/20
Fly Intel: Top five analyst initiations
05/29/20 Daiwa
Tesla initiated with an Outperform at Daiwa
05/28/20 Morgan Stanley
Tesla shift to software revenue key to unlocking bull case, says Morgan Stanley
ZM Zoom Video
$204.15 /

+24.52 (+13.65%)

05/27/20 Baird
Zoom Video price target raised to $180 from $120 at Baird
05/15/20 Citi
Zoom Video initiated with a Neutral at Citi
05/04/20 Piper Sandler
Zoom Video price target raised to $144 from $110 at Piper Sandler
04/23/20 JPMorgan
Zoom Video strength related to CEO comments on user growth, says JPMorgan
ZM Zoom Video
$204.15 /

+24.52 (+13.65%)

TSLA Tesla
$898.04 /

+63.87 (+7.66%)

PFE Pfizer
$35.47 /

-2.67 (-7.00%)

ECL Ecolab
$209.13 /

-3.72 (-1.75%)

ZM Zoom Video
$204.15 /

+24.52 (+13.65%)

TSLA Tesla
$898.04 /

+63.87 (+7.66%)

PFE Pfizer
$35.47 /

-2.67 (-7.00%)

ZM Zoom Video
$204.15 /

+24.52 (+13.65%)

TSLA Tesla
$898.04 /

+63.87 (+7.66%)

PFE Pfizer
$35.47 /

-2.67 (-7.00%)

ECL Ecolab
$209.13 /

-3.72 (-1.75%)

ZM Zoom Video
$204.15 /

+24.52 (+13.65%)

TSLA Tesla
$898.04 /

+63.87 (+7.66%)

PFE Pfizer
$35.47 /

-2.67 (-7.00%)

ECL Ecolab
$209.13 /

-3.72 (-1.75%)

TSLA Tesla
$898.04 /

+63.87 (+7.66%)

Hot Stocks
Menlo Therapeutics announces results from Phase 2 trial of FCD105 » 08:02
06/02/20
06/02
08:02
06/02/20
08:02
MNLO

Menlo Therapeutics

$2.37 /

-0.005 (-0.21%)

Menlo Therapeutics…

Menlo Therapeutics announced positive results from a Phase 2 clinical trial evaluating the preliminary safety and efficacy of FCD105, the first ever topical minocycline-based combination product, for the treatment of moderate-to-severe acne vulgaris. Study FX2016-40 enrolled 447 patients in the United States who were randomized to either FCD105 foam, 3% minocycline foam, 0.3% adapalene foam, or vehicle foam. The Company has begun preparations to conduct an End of Phase 2 meeting with the FDA before the end of this year. FCD105 showed a highly statistically significant improvement compared to vehicle for the endpoints of Investigator's Global Assessment treatment success and absolute change from baseline in mean inflammatory counts at Week 12. The proportion of patients achieving IGA treatment success in the FCD105 treatment group was 35.9% compared to 15.7% of patients in the vehicle treatment group. Absolute reduction in inflammatory lesion counts at Week 12 was -19.4 for the FCD105 treatment group compared to -15.58 for the vehicle treatment group. The trial was not originally powered to demonstrate a statistical difference between FCD105 and either 3% minocycline foam or 0.3% adapalene foam treatments; however, the majority of these comparisons did show a statistically significant improvement of FCD105 at Week 12. Numerical improvement was observed for FCD105 on all efficacy endpoints for these comparisons at Week 12. Absolute reduction in non-inflammatory lesion counts at Week 12 was also assessed with a mean lesion count reduction of -24.94 for the FCD105 treatment group compared to -22.87 for the vehicle treatment group. Although numerical improvement was shown, this was not statistically significant, which has been attributed to outlier results affecting both FCD105 and vehicle treatment groups. Conversely, absolute reduction in non-inflammatory lesion counts at Week 12 for FCD105 did show a statistically significant improvement compared to each of 3% minocycline foam and 0.3% adapalene foam. The most commonly reported treatment-emergent adverse event in the trial was upper respiratory tract infection with dry skin being the most commonly reported cutaneous adverse event. The majority of adverse events were assessed as mild in severity. There were no serious adverse events. FCD105 was comparably tolerated to vehicle in all local skin tolerability assessments with 93% or greater of severity scores being assessed as "none" or "mild" for burning/stinging, itching, dryness, scaling, erythema and hyperpigmentation.

ShowHide Related Items >><<
MNLO Menlo Therapeutics
$2.37 /

-0.005 (-0.21%)

MNLO Menlo Therapeutics
$2.37 /

-0.005 (-0.21%)

06/01/20 Northland
Menlo Therapeutics price target raised to $6 from $3.50 at Northland
06/01/20 H.C. Wainwright
Menlo Therapeutics price target raised to $3.50 from $2.50 at H.C. Wainwright
05/29/20 Cantor Fitzgerald
Menlo set up for 'successful' Q4 launch of Zilxi, says Cantor Fitzgerald
05/21/20 Northland
Menlo Therapeutics initiated with an Outperform at Northland
MNLO Menlo Therapeutics
$2.37 /

-0.005 (-0.21%)

MNLO Menlo Therapeutics
$2.37 /

-0.005 (-0.21%)

MNLO Menlo Therapeutics
$2.37 /

-0.005 (-0.21%)

Periodicals
Cities continue to vie for new Tesla Cybertruck Gigafactory, Bloomberg reports » 07:00
06/02/20
06/02
07:00
06/02/20
07:00
TSLA

Tesla

$898.04 /

+63.87 (+7.66%)

Even with less money…

Even with less money coming in due to the COVID-19 pandemic lockdowns, cities in middle America are bidding to be the home of Tesla's new Cybertruck Gigafactory, Mya Frazier of Bloomberg reports. Despite shrinking budgets and drops in tax revenue, cities are attempting to lure large companies like Tesla with billion dollar incentive packages. While questions remain on the justification of these bids, cities reportedly believe the long-term economic benefits will outweigh the cost. Even though cities like Joplin, Missouri had made public its bid to the electric automaker, cities like Tulsa, Oklahoma and Austin, Texas are considered finalists, while keeping their incentive packages a secret. Reference Link

ShowHide Related Items >><<
TSLA Tesla
$898.04 /

+63.87 (+7.66%)

TSLA Tesla
$898.04 /

+63.87 (+7.66%)

06/01/20 Morgan Stanley
SpaceX success has bearing on market's perception of Tesla, says Morgan Stanley
05/29/20
Fly Intel: Top five analyst initiations
05/29/20 Daiwa
Tesla initiated with an Outperform at Daiwa
05/28/20 Morgan Stanley
Tesla shift to software revenue key to unlocking bull case, says Morgan Stanley
TSLA Tesla
$898.04 /

+63.87 (+7.66%)

TSLA Tesla
$898.04 /

+63.87 (+7.66%)

TSLA Tesla
$898.04 /

+63.87 (+7.66%)

TSLA Tesla
$898.04 /

+63.87 (+7.66%)

TSLA Tesla
$898.04 /

+63.87 (+7.66%)

Monday
Syndicate
Digital Ally files to sell common stock, no amount given » 18:50
06/01/20
06/01
18:50
06/01/20
18:50
DGLY

Digital Ally

$1.95 /

+0.84 (+75.68%)

Aegis Capital Corp. is…

Aegis Capital Corp. is acting as the sole book-running manager for the offering.

ShowHide Related Items >><<
DGLY Digital Ally
$1.95 /

+0.84 (+75.68%)

DGLY Digital Ally
$1.95 /

+0.84 (+75.68%)

DGLY Digital Ally
$1.95 /

+0.84 (+75.68%)

DGLY Digital Ally
$1.95 /

+0.84 (+75.68%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.